Your browser doesn't support javascript.
loading
Hemodialysis Procedures for Stable Incident and Prevalent Patients Optimize Hemodynamic Stability, Dialysis Dose, Electrolytes, and Fluid Balance.
Stuard, Stefano; Ridel, Christophe; Cioffi, Mario; Trost-Rupnik, Alijana; Gurevich, Konstantin; Bojic, Marija; Karibayev, Yerkebulan; Mohebbi, Nilufar; Marcinkowski, Wojciech; Kupres, Vlasta; Maslovaric, Jelena; Antebi, Alon; Ponce, Pedro; Nada, Mamdouh; Salvador, Maria Eva Baro; Rosenberger, Jaroslav; Jirka, Tomas; Enden, Kira; Novakivskyy, Volodymyr; Voiculescu, Daniela; Pachmann, Martin; Arkossy, Otto.
Afiliación
  • Stuard S; FME Global Medical Office, 61352 Bad Homburg, Germany.
  • Ridel C; FME Global Medical Office, 94260 Fresnes, France.
  • Cioffi M; FME Global Medical Office, 80133 Napoli, Italy.
  • Trost-Rupnik A; FME Global Medical Office, 1351 Brezovica pri Ljubljani, Slovenia.
  • Gurevich K; FME Global Medical Office, Saint Petersburg 194354, Russia.
  • Bojic M; FME Global Medical Office, 75400 Zvornik, Bosnia and Herzegovina.
  • Karibayev Y; FME Global Medical Office, Almaty 050003, Kazakhstan.
  • Mohebbi N; FME Global Medical Office, 8002 Zurich, Switzerland.
  • Marcinkowski W; FME Global Medical Office, 60118 Poznan, Poland.
  • Kupres V; FME Global Medical Office, 49210 Zabok, Croatia.
  • Maslovaric J; FME Global Medical Office, 11000 Beograd, Serbia.
  • Antebi A; FME Global Medical Office, Ra'anana 4366411, Israel.
  • Ponce P; FME Global Medical Office, 1750-233 Lisboa, Portugal.
  • Nada M; FME Global Medical Office, Riyadh 12472, Saudi Arabia.
  • Salvador MEB; FME Global Medical Office, 28760 Madrid, Spain.
  • Rosenberger J; FME Global Medical Office, 04011 Kosice, Slovakia.
  • Jirka T; FME Global Medical Office, 16000 Praha, Czech Republic.
  • Enden K; FME Global Medical Office, 00380 Helsinki, Finland.
  • Novakivskyy V; FME Global Medical Office, 02099 Kyiv, Ukraine.
  • Voiculescu D; FME Global Medical Office, 013682 Bucuresti, Romania.
  • Pachmann M; FME Global Medical Office, 61352 Bad Homburg, Germany.
  • Arkossy O; FME Global Medical Office, 61352 Bad Homburg, Germany.
J Clin Med ; 13(11)2024 May 30.
Article en En | MEDLINE | ID: mdl-38892922
ABSTRACT
The demographic profile of patients transitioning from chronic kidney disease to kidney replacement therapy is changing, with a higher prevalence of aging patients with multiple comorbidities such as diabetes mellitus and heart failure. Cardiovascular disease remains the leading cause of mortality in this population, exacerbated by the cardiovascular stress imposed by the HD procedure. The first year after transitioning to hemodialysis is associated with increased risks of hospitalization and mortality, particularly within the first 90-120 days, with greater vulnerability observed among the elderly. Based on data from clinics in Fresenius Medical Care Europe, Middle East, and Africa NephroCare, this review aims to optimize hemodialysis procedures to reduce mortality risk in stable incident and prevalent patients. It addresses critical aspects such as treatment duration, frequency, choice of dialysis membrane, dialysate composition, blood and dialysate flow rates, electrolyte composition, temperature control, target weight management, dialysis adequacy, and additional protocols, with a focus on mitigating prevalent intradialytic complications, particularly intradialytic hypotension prevention.
Palabras clave